Smithkline Beecham Corp
General
Total Cases97
Active Cases--
Patents1,286
--
--
--
Ratings
Experience
Grade
Trend
DCT
L4
A
PTAB
L5
E
CAFC
L3
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 12/12/24 | MEMORANDUM ORDER re [528] Order. Signed by Judge Gregory B. Williams on 12/12/2024. (lnb) (Entered: 12/12/2024) | |
| 12/12/24 | MEMORANDUM ORDER re [528] Order. Signed by Judge Gregory B. Williams on 12/12/2024. (lnb) (Entered: 12/12/2024) | |
| 07/10/24 | Letter to Honorable Gregory B. Williams from Douglas E. McCann regarding case status. (McCann, Douglas) (Entered: 07/10/2024) | |
| 07/10/24 | Letter to Honorable Gregory B. Williams from Douglas E. McCann regarding case status. (McCann, Douglas) (Entered: 07/10/2024) | |
| 05/03/24 | REQUEST for Oral Argument by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited. (McCann, Douglas) (Entered: 05/03/2024) | |
| 05/03/24 | REQUEST for Oral Argument by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited. (McCann, Douglas) (Entered: 05/03/2024) | |
| 04/29/24 | REPLY BRIEF on Remand filed by Teva Pharmaceuticals USA Inc.. (Keller, Karen) (Entered: 04/29/2024) | |
| 04/29/24 | REPLY BRIEF on Remand filed by Teva Pharmaceuticals USA Inc.. (Keller, Karen) (Entered: 04/29/2024) | |
| 04/22/24 | APPENDIX re [535] Response to Order Response to Teva's Brief re Issues remaining to be Tried by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited. (Attachments: # [1] PTX 78, # [2] PTX 920, # [3] PTX 1084, # [4] PTX 1302, # [5] DTX 2601, # [6] DTX 2647)(McCann, Douglas) (Entered: 04/22/2024) | |
| 04/22/24 | APPENDIX re [535] Response to Order Response to Teva's Brief re Issues remaining to be Tried by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited. (Attachments: # [1] PTX 78, # [2] PTX 920, # [3] PTX 1084, # [4] PTX 1302, # [5] DTX 2601, # [6] DTX 2647)(McCann, Douglas) (Entered: 04/22/2024) |